Literature DB >> 82793

Human benefits and costs of a national screening programme for neural-tube defects.

J Chamberlain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82793     DOI: 10.1016/s0140-6736(78)92053-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Ethics, justification and the prevention of spina bifida.

Authors:  Wendy Jane Gagen; Jeffrey P Bishop
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

2.  Services for thalassaemia as a model for cost-benefit analysis of genetics services.

Authors:  B Modell; A M Kuliev
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Screening for maternal serum alpha-fetoprotein: what about the low side?

Authors:  A Lippman; J A Evans
Journal:  CMAJ       Date:  1987-04-15       Impact factor: 8.262

4.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Measuring the benefits of screening for open neural tube defects.

Authors:  J B Henderson
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

Review 6.  Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations.

Authors:  Martha S Linet; Kwang Pyo Kim; Preetha Rajaraman
Journal:  Pediatr Radiol       Date:  2008-12-16

7.  Which prescriptive screening programmes are worth while?

Authors:  J M Chamberlain
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

8.  [Alpha-1-fetoprotein screening--development and problems].

Authors:  P J Grob
Journal:  Soz Praventivmed       Date:  1981-09

9.  When do pregnant women attend for antenatal care?

Authors:  H Simpson; G Walker
Journal:  Br Med J       Date:  1980-07-12

10.  Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Authors:  P T Rowley; S Loader; R M Kaplan
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.